Posted by Michael Wonder on 01 Apr 2019
Patients to save tens of thousands on two key cancer drugs
1 April 2019 - It’s a medicine that could save Australians’ lives, but patients have not been able to afford the exorbitant cost of obtaining it - until now.
The government has decided to subsidise two key cancer drugs through the Pharmaceutical Benefits Scheme (PBS), saving patients up to $150,000 a year.
Tomorrow night’s budget will include $81.5 million to add Bavencio, otherwise known as avelumab, to the PBS for the first time.
